Binding of ciprofloxacin labelled with technetium Tc 99m versus 99mTc-pertechnetate to a live and killed equine isolate of Escherichia coil.
This paper describes a simple methodology for evaluating the bacterial binding of ciprofloxacin labelled with technetium Tc 99m. Using this methodology, the binding of 99mTc-ciprofloxacin by live Escherichia coli was compared with the binding of 99mTc-ciprofloxacin by killed E. coli and the binding of 99mTc-pertechnetate (99mTcO4-) by live E. coli. The antimicrobial effect of 99mTc-ciprofloxacin on E. coli was evaluated. Four groups were defined: live E. coli with 99mTc-ciprofloxacin, live E. coli with 99mTcO4 , killed E. coli with 99mTc-ciprofloxacin, and killed E. coli with 99mTcO4-. After 0, 2, and 4 h of incubation of 1 x 10(8) colony-forming units of E. coli suspended in 5 mL of sterile distilled water with 1.85 MBq of 99mTc-ciprofloxacin or 99mTcO4, 1 mL from each sample was centrifuged. The radioactivity of the bacterial pellet and that of the supernatant were measured separately, and the percentage of sample radioactivity attributable to bacterial binding was calculated. Of the 99mTc-ciprofloxacin, 3.6% to 5.9% was bound to live or killed E. coli; only 0.1% to 0.2% of the 99mTcO4- was bound to live E. coli (P < 0.0001). No significant difference in 99mTc-ciprofloxacin binding was found between live and killed E. coli (P = 0.887). An antimicrobial effect on E. coli was seen with 99mTc-ciprofloxacin: colony counts were reduced after 4 h. The small amount of 99mTc-ciprofloxacin binding and the lack of difference in binding between live and killed E. coli may limit the utility of this methodology in evaluating the presence of E. coli infection.
Alexander
Kate
K
Department of Veterinary Clinical Sciences, Ohio State University, College of Veterinary Medicine, 601 Vernon L. Tharp, Columbus, Ohio 43210, USA. kate.alexander@umontreal.ca
Drost
W Tod
WT
Mattoon
John S
JS
Kowalski
Joseph J
JJ
Funk
Julie A
JA
Crabtree
Amanda C
AC
D000818:Animals; D002939:Ciprofloxacin / Q000031:analogs & derivatives* / Q000378:metabolism; D015169:Colony Count, Microbial / Q000379:methods / Q000662:veterinary; D004926:Escherichia coli / Q000378:metabolism*; D004927:Escherichia coli Infections / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000662:veterinary*; D006734:Horse Diseases / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000382:microbiology; D006736:Horses; D015609:Organotechnetium Compounds / Q000378:metabolism; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000378:metabolism; D012680:Sensitivity and Specificity; D013670:Sodium Pertechnetate Tc 99m / Q000378:metabolism; D013997:Time Factors
D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C431804:Technetium Tc 99m ciprofloxacin; D002939:Ciprofloxacin; D013670:Sodium Pertechnetate Tc 99m